Company Announcements: (reported by the Company) |
No items found
|
Elevator Pitch: | Acuvax Ltd (ASX: ACU) is in the process of acquiring Biolife Science Ltd, which is developing a vaccine for breast and gastric cancers. On 22 March 2013, Acuvax shareholders voted overwhlemingly to approve the acquisition of Biolife and to raise $5m to fund Phase 2 trials of the vaccine. |
Category: | Health & biotech |
URL: | http://www.acuvax.com.au |
Operational Status: | Active |
ASX Listing Code (if applicable): | ACU |
Year of Commencement: | 2001 |
Address: | Suite 4, 16 Ord Street, WEST PERTH, WA, AUSTRALIA, 6005 |
State: | Western Australia |
Overseas Operations: | No |
Twitter: | |
Facebook: | |
Linkedin: | |
Founders: |
No items found
|
Awards won: | |